Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 207

1.

Incursions of Candida auris into Australia, 2018.

Lane CR, Seemann T, Worth LJ, Easton M, Pitchers W, Wong J, Cameron D, Azzato F, Bartolo R, Mateevici C, Marshall C, Slavin MA, Howden BP, Williamson DA.

Emerg Infect Dis. 2020 Mar 26;26(6). doi: 10.3201/eid2606.190936. [Epub ahead of print]

2.

Epidemiology, treatment and outcomes of bloodstream infection due to vancomycin-resistant enterococci in cancer patients in a vanB endemic setting.

Xie O, Slavin MA, Teh BW, Bajel A, Douglas AP, Worth LJ.

BMC Infect Dis. 2020 Mar 18;20(1):228. doi: 10.1186/s12879-020-04952-5.

3.

Clinical Characteristics and Outcomes of invasive Lomentospora prolificans Infections: Analysis of Patients in the FungiScope® Registry.

Jenks JD, Seidel D, Cornely OA, Chen S, van Hal S, Kauffman C, Miceli MH, Heinemann M, Christner M, Jover Sáenz A, Burchardt A, Kemmerling B, Herbrecht R, Steinmann J, Shoham S, Gräber S, Pagano L, Deeren D, Slavin MA, Hoenigl M.

Mycoses. 2020 Feb 21. doi: 10.1111/myc.13067. [Epub ahead of print]

PMID:
32080902
4.

The QuantiFERON Monitor® assay is predictive of infection post allogeneic hematopoietic cell transplantation.

Douglas AP, Yu L, Sundararajan V, Szer J, Ritchie D, Slavin MA, Sasadeusz J, Visvanathan K.

Transpl Infect Dis. 2020 Feb 8:e13260. doi: 10.1111/tid.13260. [Epub ahead of print]

PMID:
32034973
5.

Levofloxacin prophylaxis in patients with myeloma.

Teh BW, Harrison SJ, Worth LJ, Thursky KA, Slavin MA.

Lancet Oncol. 2020 Feb;21(2):e67. doi: 10.1016/S1470-2045(19)30824-1. No abstract available.

PMID:
32007198
6.

Risk stratification in children with cancer and febrile neutropenia: A national, prospective, multicentre validation of nine clinical decision rules.

Haeusler GM, Thursky KA, Slavin MA, Babl FE, De Abreu Lourenco R, Allaway Z, Mechinaud F, Phillips R; Australian PICNICC study group and the PREDICT network.

EClinicalMedicine. 2020 Jan 7;18:100220. doi: 10.1016/j.eclinm.2019.11.013. eCollection 2020 Jan.

7.

Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008-2019.

Jenks JD, Seidel D, Cornely OA, Chen S, van Hal S, Kauffman C, Miceli MH, Heinemann M, Christner M, Jover Sáenz A, Burchardt A, Kemmerling B, Herbrecht R, Steinmann J, Shoham S, Gräber S, Pagano L, Deeren D, Aslam S, Taplitz R, Revankar SG, Baddley J, Mehta SR, Reed S, Slavin MA, Hoenigl M.

Clin Microbiol Infect. 2020 Jan 20. pii: S1198-743X(20)30037-9. doi: 10.1016/j.cmi.2020.01.012. [Epub ahead of print]

PMID:
31972317
8.

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.

Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, Clancy CJ, Wingard JR, Lockhart SR, Groll AH, Sorrell TC, Bassetti M, Akan H, Alexander BD, Andes D, Azoulay E, Bialek R, Bradsher RW, Bretagne S, Calandra T, Caliendo AM, Castagnola E, Cruciani M, Cuenca-Estrella M, Decker CF, Desai SR, Fisher B, Harrison T, Heussel CP, Jensen HE, Kibbler CC, Kontoyiannis DP, Kullberg BJ, Lagrou K, Lamoth F, Lehrnbecher T, Loeffler J, Lortholary O, Maertens J, Marchetti O, Marr KA, Masur H, Meis JF, Morrisey CO, Nucci M, Ostrosky-Zeichner L, Pagano L, Patterson TF, Perfect JR, Racil Z, Roilides E, Ruhnke M, Prokop CS, Shoham S, Slavin MA, Stevens DA, Thompson GR, Vazquez JA, Viscoli C, Walsh TJ, Warris A, Wheat LJ, White PL, Zaoutis TE, Pappas PG.

Clin Infect Dis. 2019 Dec 5. pii: ciz1008. doi: 10.1093/cid/ciz1008. [Epub ahead of print]

PMID:
31802125
9.

Epidemiology and risks for infection following cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy.

Smibert OC, Slavin MA, Teh B, Heriot AG, Penno J, Ismail H, Thursky KA, Worth LJ.

Support Care Cancer. 2019 Nov 12. doi: 10.1007/s00520-019-05093-5. [Epub ahead of print]

PMID:
31712951
10.

Cryptococcal infection in patients with haematological and solid organ malignancy in the era of targeted and immune-based therapies.

Madigan V, Smibert O, Chen S, Trubiano JA, Slavin MA, Teh BW.

Clin Microbiol Infect. 2019 Nov 5. pii: S1198-743X(19)30583-X. doi: 10.1016/j.cmi.2019.10.028. [Epub ahead of print] No abstract available.

PMID:
31704335
11.

Corrigendum: Whole Genome Sequencing of Australian Candida glabrata Isolates Reveals Genetic Diversity and Novel Sequence Types.

Biswas C, Marcelino VR, Van Hal S, Halliday C, Martinez E, Wang Q, Kidd S, Kennedy K, Marriott D, Morrissey CO, Arthur I, Weeks K, Slavin MA, Sorrell TC, Sintchenko V, Meyer W, Chen SC.

Front Microbiol. 2019 Sep 27;10:2218. doi: 10.3389/fmicb.2019.02218. eCollection 2019.

12.

Diagnosis, management and prevention of Candida auris in hospitals: position statement of the Australasian Society for Infectious Diseases.

Ong CW, Chen SC, Clark JE, Halliday CL, Kidd SE, Marriott DJ, Marshall CL, Morris AJ, Morrissey CO, Roy R, Slavin MA, Stewardson AJ, Worth LJ, Heath CH; Australian and New Zealand Mycoses Interest Group (ANZMIG); and the Healthcare Infection Control Special Interest Group (HICSIG); both of the Australasian Society for Infectious Diseases (ASID).

Intern Med J. 2019 Oct;49(10):1229-1243. doi: 10.1111/imj.14612.

PMID:
31424595
13.

High prevalence of antibiotic allergies in cladribine-treated patients with hairy cell leukemia - lessons for immunopathogenesis and prescribing.

Meher-Homji Z, Tam CS, Siderov J, Seymour JF, Holmes NE, Chua KYL, Phillips EJ, Slavin MA, Trubiano JA.

Leuk Lymphoma. 2019 Dec;60(14):3455-3460. doi: 10.1080/10428194.2019.1633640. Epub 2019 Jul 1.

14.

Beta-Lactam and Sulfonamide Allergy Testing Should Be a Standard of Care in Immunocompromised Hosts.

Trubiano JA, Slavin MA, Thursky KA, Grayson ML, Phillips EJ.

J Allergy Clin Immunol Pract. 2019 Sep - Oct;7(7):2151-2153. doi: 10.1016/j.jaip.2019.05.051. Epub 2019 Jun 13.

15.

Microbiome transplantation and modulation of immune related adverse events.

Smibert OC, Guo CW, Khoo C, Thursky KA, Sandhu S, Slavin MA.

EClinicalMedicine. 2019 Mar 12;8:10-11. doi: 10.1016/j.eclinm.2019.03.003. eCollection 2019 Feb. No abstract available.

16.

Candidaemia and a risk predictive model for overall mortality: a prospective multicentre study.

Keighley C, Chen SC, Marriott D, Pope A, Chapman B, Kennedy K, Bak N, Underwood N, Wilson HL, McDonald K, Darvall J, Halliday C, Kidd S, Nguyen Q, Hajkowicz K, Sorrell TC, Van Hal S, Slavin MA.

BMC Infect Dis. 2019 May 21;19(1):445. doi: 10.1186/s12879-019-4065-5.

17.

FDG-PET/CT in managing infection in patients with hematological malignancy: clinician knowledge and experience in Australia.

Douglas AP, Thursky KA, Worth LJ, Harrison SJ, Hicks RJ, Slavin MA.

Leuk Lymphoma. 2019 Oct;60(10):2471-2476. doi: 10.1080/10428194.2019.1590571. Epub 2019 Apr 5.

PMID:
30947578
18.

Better Sepsis Management Rather Than Fluoroquinolone Prophylaxis for Patients With Cancer-Related Immunosuppression.

Slavin MA, Worth LJ, Seymour JF, Thursky KA.

J Clin Oncol. 2019 May 1;37(13):1139-1140. doi: 10.1200/JCO.18.01474. Epub 2019 Mar 7. No abstract available.

PMID:
30844318
19.

Impact of a hospital-wide sepsis pathway on improved quality of care and clinical outcomes in surgical patients at a comprehensive cancer centre.

Hiong A, Thursky KA, Venn G, Teh BW, Haeusler GM, Crane M, Slavin MA, Worth LJ.

Eur J Cancer Care (Engl). 2019 May;28(3):e13018. doi: 10.1111/ecc.13018. Epub 2019 Feb 13.

PMID:
30761632
20.

Utilizing genomic analyses to investigate the first outbreak of vanA vancomycin-resistant Enterococcus in Australia with emergence of daptomycin non-susceptibility.

Douglas AP, Marshall C, Baines SL, Ritchie D, Szer J, Madigan V, Chan HT, Ballard SA, Howden BP, Buising K, Slavin MA.

J Med Microbiol. 2019 Mar;68(3):303-308. doi: 10.1099/jmm.0.000916. Epub 2019 Jan 21.

PMID:
30663951

Supplemental Content

Loading ...
Support Center